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Introduction
Experimental autoimmune encephalomyelitis (EAE) is a T cell-mediated inflammatory disease of the CNS and serves as an animal model for multiple sclerosis. The autoimmune phenotype can be induced in rodents sensitized to proteins like myelin basic protein or myelin oligodendrocyte glycoprotein (MOG). The disease is initiated by infiltration of peripheral lymphocytes and macrophages into the CNS and is characterized by local inflammation and demyelination. The migration of leukocytes into the CNS is facilitated by interactions of cell surface adhesion molecules and their endothelial ligands [1] . The family of β2-integrins is involved in leukocytevascular cell interactions as well as in the communication between T cells and antigen presenting cells. The αLβ2-integrin LFA-1 (CD11a/CD18) is widely expressed by leukocytes including peripheral blood lymphocytes, monocytes, and NK cells [2] . Amongst the members of the β2 family of integrins only LFA-1 is expressed by CD4 + T cells and CD4 + CD25 + regulatory T cells (Treg) [3] . Interestingly, CD18-deficient mice, which do not express β2-integrins, showed an impaired development of thymic and peripheral Treg cells but it remained unclear, which of the β2-integrins is responsible for this phenotype [3] .
The function of LFA-1 in EAE has been extensively studied. However, in part controversial and conflicting results have been obtained. E.g. treatment with anti-LFA-1 antibodies led to either protection against EAE [4] or to more severe disease development [5] . More recently, a deficiency for LFA-1 was suggested to dampen EAE upon active induction of an autoimmune response [6] . On the other hand, adoptive transfer of wild-type encephalitogenic T cells into LFA-1 -/-mice profoundly exacerbated the EAE course in comparison to wild-type mice indicating an anti-inflammatory role of LFA-1, which would limit disease progression [7] . It remained however elusive how LFA-1 exerts its immunosuppressive effects. To gain more insight into LFA-1 functions we further characterized LFA-1 -/-mice in comparison to wild-type controls in an EAE model. Taken together, we report here that the absence of LFA-1 promotes more severe EAE with increased demyelination and increased numbers of inflammatory cells migrating into the CNS. Moreover, we demonstrate that the loss of LFA-1 led to impaired generation of Treg cells, which in turn explains the observed overshooting autoimmune response against the MOG antigen.
Results

LFA-1 -/-mice develop more severe EAE
To examine the role of LFA-1 in EAE induction we used a standard mouse model based on the subcutaneous immunization of C57BL/6 mice with MOG Wild-type mice typically developed first clinical signs of EAE between day 10 and 15 and reached the peak of disease between day 18 and 23. Clinical signs persisted on the peak level for at least 5-7 days before they slowly decreased. Interestingly, LFA-1 knock-out animals developed dramatically aggravated clinical signs and reached significantly higher clinical scores over the whole observation period (mean cumulative disease score until day 29: 31.4 vs. 14.7, p<0.0001, calculated across 3 independent experiments with n=28 or n=27 animals per group).
A typical experiment is shown in Figure 1 and Autoantigen-specific CD4 + T cells are known to be the major pathogenic factor in EAE [8] . To get information not only about total but MOG-specific CD4 + T cells we used a recently established system to detect antigen-specific T cells with high sensitivity [9] . The method is based on a short-term in vitro restimulation with the cognate antigen and subsequent staining for CD40L (CD154). This assay revealed that up to 50% of the infiltrating CD4 + T cells were specific for the autoantigen. Importantly, the frequency of MOG-specific CD4 for the experiment shown in Figure 3 ).
It is important to note that the higher cell number cannot be explained by different kinetics of lymphocyte infiltration because comparable results were obtained regardless whether both groups were analyzed at the same time point (which was not necessarily the peak of clinical signs for both groups) or the peak of the clinical score for individual animals.
As LFA-1 was shown to be involved in lymphocyte migration [10] [11] it is tempting to speculate that the higher number of MOG-specific T cells in the spinal cord of LFA-1 knock-out mice is the result of an enhanced recruitment to the site of inflammation. However, when we used the same strategy to identify MOG-specific T cells in secondary lymphoid organs, it turned out that the difference in antigen-specific T cells was already established in the spleen and the draining lymph nodes ( Figure 3B ). Therefore, LFA-1 seems to control the generation and not the distribution of antigen-specific T cells.
The production of pro-inflammatory cytokines is not altered on the level of antigen-
specific T cells
Pro-inflammatory cytokines, namely IL-17 and IFN-γ, are well recognized as a major pathogenic factor in EAE [8] . As a recent report claimed that LFA-1 critically regulates the development of Th17 cells in EAE [6] we analyzed cytokine production by autoreactive CD4 + T cells from Polyfunctional Th1 cells producing multiple effector cytokines at the same time are thought to be particularly destructive in inflammation [12] . Therefore, we also analyzed whether the frequency of IL-2, IL-17, IFN-γ double or triple producers was altered between wild-type and knock-out mice, but did not find any significant differences (data not shown). Alternatively, a change in Th2 or anti-inflammatory cytokines could influence the severity of disease. Therefore, we tested for production of IL-4 and IL-10. Only very few (< 2%) antigen-specific CD4 + T cells in the spinal cord produced these two cytokines. However, we did not observe any significant differences between LFA-1 +/+ and LFA-1 -/-T cells (data not shown).
To analyze the general capacity of T cells to produce certain cytokines we additionally used an antigen-independent stimulation with PMA and ionomycin. Also with this kind of stimulation none of the analyzed cytokines differed between knock-out and wild-type mice (data not shown).
Taken together, these results clearly show that loss of LFA-1 does not alter the cytokine pattern of autoreactive CD4 + T cells. Therefore, only the increased total number of antigen-specific, cytokine-producing cells in LFA-1 -/-mice can be accounted for the increased severity of EAE.
Decreased number of regulatory T cells in LFA-1 -/-mice
Regulatory T cells play an important role for the suppression of chronic inflammation [8, 13] . S1 ). However, we could not find any differences.
Generally, a diminished population of Tregs can be explained by either reduced generation in the thymus or altered survival and homeostasis in the periphery. To discriminate these two possibilities we directly examined Tregs in the thymus of LFA-1 -/-and LFA-1 +/+ mice. As reported earlier [14] , there were neither obvious differences in size and cellularity of the thymus nor in the distribution of CD4/CD8 thymic subsets ( Figure 6B and data not shown). Also histologically the thymus did not display any abnormalities. However, when we analyzed the frequency of FoxP3 shows that the P61-depleted animals developed EAE scores absolutely comparable to LFA-1 -/-mice. Interestingly, they even showed accelerated disease development.
Discussion
Until now the exact role of LFA-1 in the pathogenesis of EAE is still elusive. There are several early studies using blocking monoclonal antibodies against LFA-1 which provided conflicting results. In one case this treatment resulted in a clear amelioration [4] while Welsh et al. [5] reported an augmentation of EAE. In a third study [15] showing that LFA-1 enhances T cell activation [16] [17] . Obviously, in this specific EAE model the effect of LFA-1 on Treg generation is more dominant and determines the final biological outcome. We recently reported a similar finding for the inducible costimulator ICOS which augments the long-term survival of effector as well as regulatory T cells [18] . Dependent on the biological context, ICOS costimulation can result in pro-inflammatory as well as antiinflammatory effects. Now, LFA-1 seems to be another example of such a Janus-faced immune regulator.
Involvement of Tregs in the pathogenesis of EAE has been documented in numerous studies.
Depletion of CD25 + cells in vivo usually resulted in an exacerbation of the disease whereas transfer of high numbers of regulatory T cells protected animals from EAE (reviewed in [13] ).
The general role of ß2-integrins for the development of Tregs have been first shown by Marski et al. [3] who observed a substantial reduction of Tregs in CD18 knock-out mice, which lack LFA-1 (CD11a/CD18), Mac-1 (CD11b/CD18), integrin αX (CD11c/CD18), and CD11d/CD18 at the same time. A very recent study reported reduced numbers of Tregs in secondary lymphoid organs of LFA-1 knock-out mice [19] . However, in contrast to our results they did not detect any differences in the thymus.
A number of studies suggested that Tregs exert their suppressive function on effector T cells indirectly by modifying the function of antigen-presenting dendritic cells. Interestingly, a recent in vitro study showed that LFA-1 is important for the formation of dendritic cell/Treg aggregates because LFA-1 -/-Tregs were no longer able to inhibit the maturation of cocultured dendritic cells [20] . Similar effects were also observed in a mixed human/mouse suppression system [21] . We show here that LFA-1 deficiency results in a reduced Treg/effector cell ratio in the inflamed CNS. ICAM-1, a ligand of LFA-1, is expressed on thymic stromal cells [22] . Therefore, LFA-1 potentially increases the physical contact between thymocytes and stromal cells resulting in enhanced T cell receptor triggering. Increased T cell receptor signalling during thymocyte selection favours the generation of naturally occurring Tregs [23] , which would explain the contribution of LFA-1 to the generation of naturally occurring Tregs.
So far, LFA-1 has been mainly recognized as a molecule regulating the migration of lymphocytes. Generally, the migration of LFA-1-deficient T cells to the peripheral lymph nodes is impaired, resulting in significantly smaller lymph nodes [10, 14] . However, upon immunization with MOG-peptide we observed that these differences in cellularity in lymph nodes between wildtype and LFA-1 knock-out mice is more or less levelled out (data not shown). In the context of EAE and transendothelial migration, Laschinger et al. [11] demonstrated that encephalitogenic T cells do not use LFA-1 for the initial adhesion to the endothelium of the blood/brain barrier.
Instead, LFA-1 was involved in the later phases of migration into the CNS parenchyma.
However, it should be noted that these results were obtained for the healthy spinal cord and that the role of LFA-1 for migration could be different during later stages of an EAE disease, in which other integrin interactions may compensate for the lack of LFA-1. In our study, we did not directly 
Materials and methods
Mice
LFA-1-deficient mice [24] were obtained from the Jackson Laboratories and were backcrossed to C57BL/6 for 13 generations. We further crossed them with C57BL/6 wild type mice and used littermates of LFA-1 +/-inter-se matings for the experiments. Animal handling and experiments were conducted according to the German animal protection laws and approved by the responsible governmental authority.
EAE induction
For EAE induction, six to ten weeks old mice were anaesthetized with ketamine (94 mg/kg body Similarly, the numbers of inflammatory infiltrates were counted in all transverse spinal cord sections and the mean per section was calculated.
Cell preparation
To prepare single cell suspensions from spleen, peripheral lymph nodes, or thymus organs were cut into small pieces and meshed through a sieve. For cell preparation from spinal cords mice were perfused with 25 ml PBS via the left cardiac ventricle under deep anaesthesia. The spinal cord was removed and collected in cold medium (RPMI 1640, 0.5% BSA). A single cell suspension was prepared using the gentleMACS dissociator (Miltenyi Biotec) and digestion with 0.5 mg/ml collagenase D and 20 µg/ml DNase I (both from Roche) for 30 min at 37°C. To stop digestion 10 mmol EDTA was added for the last 5 min. To remove residual pieces of tissue the suspension was filtered through a 100 µm filter. Cells were counted using a Guava PCA capillary flow cytometer and ViaCount solution (Millipore).
Flow cytometry
Single cell suspensions from spinal cord, lymph nodes, spleen, or thymus were suspended in 
Analysis of antigen-specific cells and cytokine production
For analysis of antigen-specific cells and cytokine production cells were suspended at 5x10 6 per ml in medium (RPMI 1640, 10% FCS) and restimulated with 25 µg/ml MOG 35-55 (MoBiTec) for 6 h at 37°C. After 2 h of culture, 5 µg/ml brefeldin A (Sigma) was added.
After staining of cell surface antigens and live/dead discrimination with Pacific Orange, cells
were fixed with formaldehyde and permeabilised with saponin (buffer set from eBioscience).
Unspecific binding sites were blocked with 100 µg/ml 2.4G2 and 50 µg/ml purified rat Ig (Nordic) and cells were stained intracellularly with the following fluorophore-conjugated mAb: FITC- Cells were further analyzed by flow cytometry as described above.
Statistical analysis
All data were analyzed using GraphPad Prism software using either Student´s t test to determine differences between two groups, Kruskal-Wallis test for the scoring curves, or Pearson test for correlation of two parameters. Variation within experimental groups is reported as SEM. 
